CDs for Regulating Cholesterol Homeostasis in Atherosclerosis
The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening
Tag: nanocarrier
Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform
Acute myeloid leukaemia (AML), accounts for 30 % of adult leukaemia cases, predominantly affects individuals over 60. The standard “7 + 3” intensive
Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
Nanoparticle-based drug delivery systems have been designed to treat various diseases. However, many problems remain, such as inadequate tumor targeting
D-maltose clicked to β-cyclodextrin: preparation and its application as a biocompatible drug delivery nanovehicle
D-maltose-clicked derivative of β-cyclodextrin (β-CD-M) was synthesized to compare and investigate its capability as an anticancer drug nanocarrier [1]. The